**Core Concept**
The question requires knowledge of fluoroquinolone antibiotics and their efficacy against Mycobacterium leprae, the causative agent of leprosy. Fluoroquinolones are a class of broad-spectrum antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV, essential for bacterial DNA replication.

**Why the Correct Answer is Right**
Moxifloxacin is a fluoroquinolone antibiotic that has been shown to have high activity against Mycobacterium leprae. Its mechanism of action involves inhibiting bacterial DNA gyrase and topoisomerase IV, which are essential for DNA replication and transcription. This results in bacterial cell death. Moxifloxacin has been investigated as an alternative to traditional multidrug therapy regimens for leprosy due to its potential to reduce the duration of treatment and improve patient compliance.

**Why Each Wrong Option is Incorrect**
**Option A:** Ofloxacin is another fluoroquinolone antibiotic, but it has not been specifically studied for its efficacy against Mycobacterium leprae.
**Option B:** Levofloxacin is a fluoroquinolone with broad-spectrum activity, but it is not typically used for leprosy treatment.
**Option C:** Ciprofloxacin is a fluoroquinolone antibiotic with a broad spectrum of activity, but it is not specifically indicated for leprosy treatment.

**Clinical Pearl / High-Yield Fact**
Moxifloxacin's high activity against Mycobacterium leprae makes it a promising alternative for multidrug therapy regimens, potentially reducing treatment duration and improving patient outcomes.

**Correct Answer:** C. Moxifloxacin